Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Theravance Biopharma Earnings Preview


Benzinga | Feb 22, 2021 10:16AM EST

Theravance Biopharma Earnings Preview

Theravance Biopharma (NASDAQ:TBPH) releases its next round of earnings this Tuesday, February 23. Here is Benzinga's essential guide to Theravance Biopharma's Q4 earnings report.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Sell-side analysts are expecting Theravance Biopharma's loss per share to be near $1.02 on sales of $20.85 million. In the same quarter last year, Theravance Biopharma announced EPS of $1.17 on revenue of $29.50 million.

Why Analyst Estimates And Earnings Surprises Are Important

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

The Wall Street estimate would represent a 12.82% increase in the company's earnings. Sales would be down 29.32% on a year-over-year basis. In comparison to analyst estimates in the past, here is how the company's reported EPS stacks up:

Quarter Q3 2020 Q2 2020 Q1 2020 Q4 2020EPS Estimate -0.97 0.98 -1.07 -1.13EPS Actual -1.16 -1 -1.14 -1.17Revenue Estimate 18.58 M 19.64 M 18.13 M 16.84 MRevenue Actual 18.26 M 15.01 M 19.86 M 29.50 M

Stock Performance

Over the last 52-week period, shares are down 18.95%. Given that these returns are generally negative, long-term shareholders won't be happy going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Theravance Biopharma is scheduled to hold the call at 17:00:00 ET and can be accessed here.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC